Journal Article

Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments

Whaibeh, Emile, Mahmoud, Hossam, Naal, Hady, Smith, Alyson

2022

Overview

Purpose of Review Telehealth-delivered medication-assisted treatment for opioid use disorder (tele-MOUD) has received increased attention, with the intersection of the opioid epidemic and COVID-19 pandemic, but research on recent developments is scattered. We critically review recent literature on tele-MOUD and synthesize studies reporting primary data under four themes: clinical effectiveness, non-clinical effectiveness, perceptions, and regulatory considerations. Recent Findings Despite increasing publications, most failed to include long-term comprehensive assessments. Findings indicate favorable outcomes such as improvements in retention and abstinence rates, positive experiences, and improved feasibility with the relaxation of regulatory measures. With increased adoption, clinician and patient perceptions appeared largely positive. Negative findings, albeit minor, were primarily associated with workflow adaptation difficulties and limited access of underserved populations to technology and internet connection. Summary Additional financial, logistical, outreach, and training support for clinicians, patients, and support staff is recommended, in addition to permanent evidence-based regulatory reforms, to scale and optimize tele-MOUD services. Comprehensive recommendations to overcome limitations are expanded therein.

• Publisher: Springer US,Springer Nature B.V
• Subject: COVID-19 / Medicine / Medicine & Public Health / Narcotics / Psychiatry / Psychiatry in the Digital Age (J Shore / Psychiatry in the Digital Age (J Shore, Section Editor) / Regulatory reform / Section Editor / Substance use disorder / Telemedicine / Topical Collection on Psychiatry in the Digital Age